ClinicalTrials.gov
ClinicalTrials.gov Menu

Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00765778
Recruitment Status : Unknown
Verified October 2008 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : October 3, 2008
Last Update Posted : October 16, 2008
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center

Brief Summary:

Detailed activity:

  • Family members and caregivers of carrier residents will be screened for ESBL and MRSA. Screening will be performed by obtaining nares and perirectal cultures. Nares cultures will be obtained by ward staff or research personnel who are experienced in performing this activity: a moisture swab will be applied gently to the distal part of both nares. Perirectal cultures, will be taken by swab, who will be applied to the perirectal area, either by staff as mentioned above, or will be given to the participants to perform by himself (with explanation on how to perform it).
  • The Family and Caregiver Screening Form will be filled out; results of screening will be added to the forms. This data will be stored after removal of all Family members' identifiers for further analysis.
  • In order to allow follow up, a list linking between the Family members' study number and his identifying details will be kept separately in the rehabilitation center. This list will not be transferred elsewhere.

Condition or disease
Bacterial Infection

Detailed Description:

Detailed activity:

  • Family members and caregivers of carrier residents will be screened for ESBL and MRSA. Screening will be performed by obtaining nares and perirectal cultures. Nares cultures will be obtained by ward staff or research personnel who are experienced in performing this activity: a moisture swab will be applied gently to the distal part of both nares. Perirectal cultures, will be taken by swab, who will be applied to the perirectal area, either by staff as mentioned above, or will be given to the participants to perform by himself (with explanation on how to perform it).
  • The Family and Caregiver Screening Form will be filled out; results of screening will be added to the forms. This data will be stored after removal of all Family members' identifiers for further analysis.
  • In order to allow follow up, a list linking between the Family members' study number and his identifying details will be kept separately in the rehabilitation center. This list will not be transferred elsewhere.
  • Providing results to family members: results of screening will be / will not be reported to the participant (family member) based on local decision in each center.

Study Type : Observational
Estimated Enrollment : 400 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community:the Role of Family Members and Caregivers in Dissemination of MDR in Rehabilitation Centers
Study Start Date : October 2008
Estimated Primary Completion Date : October 2009
Estimated Study Completion Date : January 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Family members and caregivers carriers of patients who are carriers of resistant bacteria /Family members and caregivers of patients who are carriers of resistant bacteria [ Time Frame: one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Family members or caregivers of patient hospitalized in rehabilitation centers and who is known carrier of the target resistant population.
Criteria

Inclusion Criteria:

  • Family members or caregivers of patient hospitalized in rehabilitation center and who is known carrier of the target resistant population.
  • Participating member older than 18 years, who attend the patient at least once a week, will be eligible for inclusion.

Exclusion Criteria:

  • Age 18 years or less, attending the patient less than once a week.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00765778


Contacts
Contact: yaffa lerman, MD 97252-4266910 yaffale@tasmc.health.gov.il

Locations
Israel
Tasmc Not yet recruiting
Tel-aviv, Israel
Contact: Yaffa lerman, MD    97252-4266910    yaffale@tasmc.health.gov.il   
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Yehuda carmeli, MD TASMC

Publications:
Responsible Party: yehuda carmeli, Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT00765778     History of Changes
Other Study ID Numbers: TASMC-08-YC-249-CTIL
First Posted: October 3, 2008    Key Record Dates
Last Update Posted: October 16, 2008
Last Verified: October 2008

Keywords provided by Tel-Aviv Sourasky Medical Center:
resistant bacteria rehabilitation centers

Additional relevant MeSH terms:
Bacterial Infections
Anti-Infective Agents
Anti-Bacterial Agents